New COVID medicine listing

alert warning
Oral antiviral Paxlovid to be added to the PBS from 1 May as a treatment for COVID-19 Community pharmacists can expect to see PBS-subsidised scripts of the oral anti-viral medicine Paxlovid (nirmatrelvir and ritonavir) from 1 May 2022. Paxlovid is a prescription-only medicine that can be used by patients with mild-moderate COVID-19 who have a

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous "We've been so inspired by watching everyone rise to the challenge"
Next Taking vaccination to the people